Latest Articles
Phase 3 Clinical Trials Testing Endometrial Cancer Therapies - Physician's Weekly
Phase 3 Clinical Trials Testing Endometrial Cancer Therapies Physician's Weekly
Published: Oct. 2, 2026, 4:30 a.m.
Phase 3 Clinical Trials Testing Endometrial Cancer Therapies - physiciansweekly.com
Phase 3 Clinical Trials Testing Endometrial Cancer Therapies physiciansweekly.com
Published: Oct. 1, 2026, 9:07 p.m.
Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy - Clinical Trials Arena
Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy Clinical Trials Arena
Published: June 26, 2026, 4:52 p.m.
UCLA alumnus’s pioneering endometriosis treatment plans to enter clinical trials - Daily Bruin
UCLA alumnus’s pioneering endometriosis treatment plans to enter clinical trials Daily Bruin
Published: June 18, 2026, 4:55 p.m.
Pfizer targets VEGF bispecific white space | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Pfizer targets VEGF bispecific white space | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Published: May 21, 2026, 12:46 p.m.
MSD’s sac-TMT meets primary endpoints in Phase III endometrial cancer trial - Clinical Trials Arena
MSD’s sac-TMT meets primary endpoints in Phase III endometrial cancer trial Clinical Trials Arena
Published: May 18, 2026, 4:34 p.m.
Emerging Clinical Trials and Future Therapeutic Strategies in Recurrent Endometrial Cancer - OncLive
Emerging Clinical Trials and Future Therapeutic Strategies in Recurrent Endometrial Cancer OncLive
Published: May 14, 2026, 12:06 a.m.
SGO 2026 – GSK bucks the B7-H4 trend | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
SGO 2026 – GSK bucks the B7-H4 trend | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Published: April 13, 2026, 12:32 p.m.
SGO 2026 – BioNTech’s Enhertu me-too comes up short | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
SGO 2026 – BioNTech’s Enhertu me-too comes up short | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Published: April 13, 2026, 10:30 a.m.
Endometriosis Pain Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma, Abbvie - Barchart.com
Endometriosis Pain Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma, Abbvie Barchart.com
Published: March 4, 2026, 1:30 p.m.
Link copied to clipboard!